Pharmaceutical composition and method for the treatment of colit

Details Pharmaceutical composition and method for the treatment of colit Pharmaceutical composition and method for the treatment of colit

1989-06-26

1990-10-02

Rose, Shep K.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Ortho-hydroxybenzoic acid or derivative doai

A61K 3160

Patent

active

049607650

ABSTRACT:
A pharmaceutical composition containing as active ingredient 5-aminosalicylic acid or a pharmaceutically acceptable salt or ester thereof allow the treatment of colitis ulcerosa or Crohn's disease by oral administration. A particular slow-release tablet formation and its preparation is disclosed.

REFERENCES:
patent: 2738303 (1956-03-01), Blythe
patent: 2805977 (1957-09-01), Robinson et al.
patent: 2928769 (1960-03-01), Gaunt
patent: 2928770 (1960-03-01), Bardami
patent: 2951792 (1960-09-01), Swintosky
patent: 2987445 (1961-06-01), Levesque
patent: 2996431 (1961-08-01), Barry
patent: 3017329 (1962-01-01), Dulmage, Sr.
patent: 3039933 (1962-06-01), Goldman
patent: 3043747 (1962-07-01), Long
patent: 3054724 (1962-09-01), Raff
patent: 3062720 (1962-11-01), Costello
patent: 3078216 (1963-02-01), Groif
patent: 3080294 (1963-03-01), Eberperd
patent: 3081233 (1963-03-01), Enz et al.
patent: 3108046 (1963-10-01), Harbit
patent: 3131123 (1964-04-01), Masquelier
patent: 3133863 (1964-05-01), Tansey
patent: 3143472 (1964-08-01), Lappas et al.
patent: 3388041 (1968-06-01), Gaus et al.
patent: 3431338 (1969-03-01), Munzel
patent: 3784683 (1974-01-01), Prillig et al.
patent: 3906086 (1975-09-01), Guy et al.
patent: 3950521 (1976-04-01), Higuchi et al.
patent: 4066756 (1978-01-01), Orr et al.
patent: 4190716 (1980-02-01), Parkinson et al.
patent: 4193985 (1980-03-01), Bechgaard et al.
patent: 4211777 (1980-07-01), Chambers
patent: 4221810 (1980-09-01), Tahara et al.
patent: 4298595 (1981-11-01), Parkinson et al.
patent: 4312806 (1982-01-01), Lambert et al.
patent: 4350689 (1982-09-01), Sloboda
patent: 4374932 (1983-02-01), Pitzele et al.
patent: 4412992 (1983-11-01), Chan
patent: 4440754 (1984-04-01), Sorenson
patent: 4440763 (1984-04-01), Lover
patent: 4440765 (1984-04-01), Diamond et al.
patent: 4455305 (1984-06-01), Rokus
patent: 4476553 (1984-11-01), Halskov
patent: 4489197 (1984-12-01), Wang et al.
patent: 4496553 (1985-01-01), Halskov
patent: B14496553 (1988-06-01), Halskov
patent: 4526933 (1985-07-01), Wang et al.
patent: 4539198 (1985-09-01), Powell
patent: 4540685 (1985-09-01), Bauer
patent: 4559330 (1985-12-01), Agback
patent: 4591584 (1986-05-01), Agback
patent: 4632921 (1986-12-01), Bauer
patent: 4657900 (1987-04-01), Powell et al.
patent: 4663308 (1987-05-01), Saffran et al.
patent: 4664256 (1987-05-01), Halskov
patent: 4699902 (1987-10-01), Bauer
patent: 4755544 (1988-07-01), Makino et al.
patent: 4780318 (1988-10-01), Appelgren et al.
patent: 4783487 (1988-11-01), Brune
patent: 4837229 (1989-06-01), Rokos et al.
patent: 4851443 (1989-07-01), Brune
patent: 4880794 (1989-11-01), Halskov
patent: 4990474 (1990-02-01), Theewes
Skarberg Lakartidningen 63(3y): 3122-3, Aug. 24, 1966, "A Case of Ulcerative Colitis Treated with P-Aminosalicylic Acid".
Halskov CA.95:225633q (1981) of PCT WO81/02671, Oct 1, 1981.
Lover CA.98:22288a (1982) of EP62000 Oct. 6, 1982.
Roediger et al. CA. 104:102268b (1986) of Biochem. Pharmacol. 35(2): 221-5 (1986).
Nielsen et al. CA.108:216019j (1988) of Pharmacol.Toxicol. 62(y): 223-6 (1988).
Peskar CA.110:107467z (1988) of Klin. Wochen Schr. 66(22): 1147-1150 (1988).
Roediger et al. CA.111:89788u (1989) of Pharmacology 39(1): 39-43 (1989).
Meyers Am J. Gastroenterol. 83(1):64-7, Jan. 1988, "The Place of Oral 5-Aminosalicylic Acid in the Therapy of Ulcerative Colitis".
Wagner, J., "Enteric Coatings", Chapter 23, Biopharmaceutics and Relevant Pharmacokinetics, Hamilton, Ill., Drug Intelligence Publications, 1971, pp. 158-165.
Thompson, H. et al., "History, Literature, and Theory of Enteric Coatings", Journal of the American Pharmaceutical Association, pp. 135-138.
Drucker, M. et al., "Factors Affecting Acetylation In-Vivo of Para-Amino-Benzoic Acid by Human Subjects", Clin. Sci., 1964, 27, 133-141.
Pieniaszek, Jr. et al., Journal of Pharmaceutical Sciences, vol. 68, No. 10, Oct. 1979, pp. 1323-1325.
Beilsteins Handbuch der Organischen Chemie, 4th Edition, Julius Springen Verlag (Berlin 1931), vol. XLV, p. 583.
Merck Index, Ninth Edition, pp. 66-67 (1976).
Goodman et al., "Ulcerative Colitis", Clinical Gastroenterology, 1978, pp. 3-16, 25, 73-74, 109-124, 128.
Kirsner, JAMA, Feb. 8, 1980, vol. 243, No. 6.
Khan et al., "An Experiment to Determine the Active Therapeutic Moiety of Sulphasalazine", Lancet 2, Oct. 29, 1977, pp. 892-895.
Peppercorn et al., Gastroenterology, vol. 64, No. 2, 1973, pp. 240-245.
Willoughby et al., Scand J. Gastroent. 1980, 15, pp. 715-719.
Fischer et al., J. Chromatography, 162 (1979), pp. 237-243.
van Hees et al., Lancet, 1, 1978, p. 277.
van Hees et al., Gut, 1979, 20, pp. 300-304.
Schroder et al., Clin. Pharm. and Ther., vol. 13, No. 4, 1972.
Klotz et al., New Engl. J. of Med., 303, No. 26, Dec. 25, 1980, pp. 1499-1502.
Binder et al., "Disodium Cromoglycate in the Treatment of Ulcerative Colitis and Crohn's Disease", Gut, vol. 22, 1981, pp. 55-60.
Shafii et al, "Absorption, Enteroheptic Circulation, and Excretion of 5-Aminosalicylic Acid in Rates", Gastroenterology, vol. 77, No. 5, 1982, pp. 297-299.
Rasmussen et al, "Treatment of Crohn's Disease With Peroral 5-Amino-Salicylic Acid", Gastroenterology, 1983, vol. 85, pp. 1350-1353.
Heatley et al, "Disodium Cromoglycate in the the Treatment of Chronic Proctitis", Gut, 1975, 16, pp. 559-563.
Mani et al, "Treatment of Ulcerative Colitis with Oral Disodium Cromoglycate", The Lancet, Feb. 28, 1976, pp. 439-441.
Dronfield et al, "Comparative Trail of Sulphasalazine and Oral Sodium Cromoglycate in the Maintenance of Remission in Ulcerative Colitis, Gut, 1978, 19, pp. 1136-1139.
Buckell, "Controlled Trial of Disodium Cromoglycate in Chronic Persistent Ulcerative Colitis", Gut, 1978, 19, pp. 1140-1143.
Willoughby et al, "Comparison of Disodium Cromoglycate and Sulphasalazine as Maintenance Therapy for Ulcerative Colitis", The Lancet, Jan. 20, 1979, pp. 119-122.
Kakemi, Chem Abst., vol. 67, #115435W (1967).
Vavilin, Chem. Abst., vol. 77, #49594a (1972).
Wagner, Chem Abst., vol. 79, #45733p (1973).
Badawi, Chem. Abst., vol. 94, #127217x (1981).
Campieri et al, A Double-Blind Clinical Trail to Compare the Effects of 4-Aminosalicylic Acid to 5-Aminosalicylic Acid in Topical Treatment of Ulcerative Colitis", Digestion 29, 1984, pp. 204-208.
Selby et al, "Topical Treatment of Distal Ulcerative Colitis with 4-Amino-Salicylic Acid Enemas", Digestion 29, 1984, pp. 231-234.
Gandolfo et al, "Treatment of Distal Colitis With 4-ASA Enemas", Abstracts of Papers 1391, Gastroenterology, vol. 88, No. 5, Part 2.
Campieri, "Topical Treatment of Ulcerative Colities With 5-Aminosalicyclic Acid (5-ASA) and 4-Aminosalicylic Acid (4-ASA) Enemas".
Gandolfo, J. et al, "4-Aminosalicylic Acid Retention Enemas in Treatment of Distal Colitis", Digestive Diseases and Sciences, vol. 32, No. 7, Jul. 1987, pp. 700-704.
Walt, R. et al, "Colitis Associated With Non-Steroidal Anti-Inflammatory Drugs", British Medical Journal, vol. 288, Jan. 21, 1984, p. 238.
Gilat, T. et al, "Prostaglandins and Ulcerative Colitis", Gastroenterology, May 1979, p. 1083.
Campierei, M. et al, "Prostaglandins Indomethacin and Ulcerative Colitis", Gastroenterology, Jan. 1980, p. 193.
Gould, S. et al, "Studies of Prostaglandins and Sulphasalazine in Ulcerative Colitis", Prostaglandins and Medicine, 6, 1981, pp. 165-182.
Rampton, D. et al, "Prostaglandin Synthesis Inhibitors in Ulcerative Colitis: Flurbiprofen Compared With Conventional Treatment", Prostaglandins, vol. 21, No. 3, Mar. 1981, pp. 417-425.
Rampton, D. et al, "Relapse of Ulcerative Proctocolitis During Treatment With Non-Steroidal Anti-Inflammatory Drugs, Postgraduate Medical Journal, No. 57, May 1981, pp. 297-299.
Badawi, A. et al, "Drug Release From Matrices Made of Polymers With Reacting Sites", International Journal of Pharmaceutics, 6, 1980, pp. 55-62.
Goldman et al, Gastroenterology, vol. 65, No. 1, 1973, pp. 166-169.
Goldman et al, The New England Journal of Medicine, vol. 293, No. 1, pp. 20-23.
Physician's Desk Reference, p. 1302, copyright 1969.
Physician's Desk Reference, p. 985, copyright 1978.
Pentikainen et al, American Review of Respiratory Disease, vol. 108, 1973.
Wagner et al

Affiliated with

Also associated with

Rating

Pharmaceutical composition and method for the treatment of colit does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutical composition and method for the treatment of colit, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical composition and method for the treatment of colit will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-292563